RxDoctor Payments Data

Andrew Evans

Hematology · Rochester, NYNPI 1730322660

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,594 of the $4,594 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Roche Diagnostics Corporation.

$4,594in general payments, 2019–2025

Across 1 payment — averaging $4594.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$5K
$610,038in research payments, 2019–2025

Across 73 payments — averaging $8356.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ventana Medical Systems, Inc.$610K

What the payments were for

  • Speaking & faculty fees$4,594100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche Diagnostics Corporation1$4,594

How this compares

$4,594 in reported general payments places this provider in the 65th percentile of 157 hematology providers in New York.

See all hematology providers in New York

Medicare billing

Part B allowed, 2024
$42,315
Medicare patients
221
Services billed
1,018

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →